Scer\GAL4how-24B-mediated expression of CadN7b-13b-18a.Scer\UAS does not affect the survival rate during embryogenesis, but induces robust (95.5%) lethality during larval stages. Larvae exhibit reduced locomotion and remain small in size prior to death, but display no apparent abnormality in muscle morphology.
Scer\GAL4elav.PU-mediated expression of CadN7b-13b-18a.Scer\UAS induces no abnormality through both the embryonic and larval stages.
Scer\GAL4elav.PU/CadN7b-13b-18a.UAS partially rescues CadN405/CadNM19
Scer\GAL4elav-C155/CadN7b-13b-18a.UAS partially rescues CadN405
Scer\GAL4how-24B/CadN7b-13b-18a.UAS fails to rescue CadN405/CadNM19
Scer\GAL4how-24B-mediated expression of CadN7b-13b-18a.Scer\UAS has no effect on the lethality of CadNM19/CadN405.
Scer\GAL4elav.PU-mediated expression of CadN7b-13b-18a.Scer\UAS partially rescues the lethality of CadNM19/CadN405 - animals now survive through to the adult stage, but fail to produce progeny.
The mistargeting and growth cone morphology defects seen in CadN405 mutant R7 cells at 17% and 35% APF are substantially rescued by expression of CadN7b-13b-18a.Scer\UAS under the control of Scer\GAL4elav-C155.